|
|
(总n= 377) |
幸存者(n= 292) |
Nonsurvivor (n= 85) |
|
| 实验室结果 |
| 白细胞计数×109/L |
7.545 (5.510 - -10.035) |
7.140 (5.380 - -9.540) |
8.550 (6.235 - -12.075) |
| ＜4 |
24/376 (6.4) |
21/291 (7.2) |
3/85 (3.5) |
| 4到10 |
257/376 (68.4) |
205/291 (70.4) |
52/85 (61.2) |
| ＞10 |
95/376 (25.3) |
65/291 (22.3) |
30/85 (35.3) |
| 淋巴细胞计数,×109 / L |
1.105 (0.803 - -1.468) |
1.150 (0.890 - -1.520) |
0.810 (0.560 - -1.250) |
| ＜1 |
156/376 (41.5) |
102/291 (35.1) |
54/85 (63.5) |
| ≥1 |
220/376 (58.5) |
189/291 (64.9) |
31/85 (36.5) |
| 血红蛋白,mg / dL |
14.8±2.0 |
14.9±1.8 |
14.5±2.6 |
| < 12.5 |
38/376 (10.1) |
20/291 (6.9) |
18/85 (21.2) |
| ≥12.5 |
338/376 (89.9) |
271/291 (93.1) |
67/85 (78.8) |
| 血小板计数,×109 / L |
218.000 (177.000 - -274.750) |
225.000 (179.000 - -281.000) |
196.000 (159.000 - -251.500) |
| ＜100 |
9/376 (2.4) |
7/291 (2.4) |
2/85 (2.4) |
| ≥100 |
367/376 (97.6) |
284/291 (97.6) |
83/85 (97.6) |
| 乳酸脱氢酶,U / L |
344.0 (266.5 - -462.0) |
325.0 (258.0 - -414.5) |
458.0 (310.0 - -646.0) |
| ≤250 |
70/365 (19.2) |
63/282 (22.3) |
7/83 (8.4) |
| > 250 |
295/365 (80.8) |
219/282 (77.7) |
76/83 (91.6) |
| 铁蛋白,ng / mL |
854.0 (472.0 - -1500.0) |
768.5 (470.8 - -1406.5) |
1131.0 (512.5 - -1942.5) |
| < 600 |
112/315 (35.6) |
90/238 (37.8) |
22/77 (28.6) |
| ≥600 |
203/315 (64.4) |
148/238 (62.2) |
55/77 (71.4) |
| c反应蛋白,mg / L |
112.3 (63.6 - -181.7) |
101.3 (55.1 - -167.2) |
143.8 (99.1 - -226.1) |
| ＜50 |
58/309 (18.8) |
52/241 (21.6) |
6/68 (8.8) |
| ≥50 |
251/309 (81.2) |
189/241 (78.4) |
62/68 (91.2) |
| 原降钙素,ng / mL |
0.27 (0.11 - -0.93) |
0.18 (0.09 - -0.59) |
0.73 (0.25 - -1.84) |
| < 0.1 |
15/70 (21.4) |
14/48 (29.2) |
1/22 (4.5) |
| 0.1 < 0.5 |
28/70 (40.0) |
20/48 (41.6) |
8/22 (36.4) |
| ≥0.5 |
27/70 (38.6) |
14/48 (29.2) |
13/22 (59.1) |
| 肺动脉栓塞,mg / L |
0.49 (0.28 - -0.93) |
0.46 (0.27 - -0.90) |
0.65 (0.37 - -1.14) |
| < 0.5 |
184/364 (50.6) |
156/283 (55.1) |
28/81 (34.6) |
| 0.5到1.0 |
101/364 (27.7) |
71/283 (25.1) |
30/81 (37.0) |
| > 1.0 |
79/364 (21.7) |
56/283 (19.8) |
23/81 (28.4) |
| 肌酐,mg / dL |
0.97 (0.79 - -1.21) |
0.90 (0.76 - -1.12) |
1.19 (0.96 - -1.58) |
| < 1.5 |
314/363 (86.5) |
254/278 (91.4) |
60/85 (70.6) |
| ≥1.5 |
49/363 (13.5) |
24/278 (8.6) |
25/85 (29.4) |
| 丙氨酸转氨酶,U / L |
35.0 (22.0 - -58.5) |
38.0 (22.8 - -61.0) |
30.5 (18.3 - -51.8) |
| ≤40 |
181/314 (57.6) |
128/234 (54.7) |
53/80 (66.3) |
| > 40 |
133/314 (42.4) |
106/234 (45.3) |
27/80 (33.7) |
| 动脉pH值 |
7.44 (7.42 - -7.46) |
7.44 (7.42 - -7.47) |
7.43 (7.4 - -7.46) |
| < 7.40 |
37/370 (10.0) |
19/286 (6.6) |
18/84 (21.4) |
| 7.40 - -7.47 |
277/370 (74.9) |
221/286 (77.3) |
56/84 (66.7) |
| > 7.47 |
56/370 (15.1) |
46/286 (16.1) |
10/84 (11.9) |
| 动脉血氧饱和度,% |
90.5 (86.9 - -93.9) |
91.0 (87.0 - -94.0) |
90.0 (84.2 - -92.8) |
| < 90 |
161/370 (38.4) |
121/286 (42.3) |
40/84 (47.6) |
| ≥90 |
209/370 (61.6) |
165/286 (57.7) |
44/84 (52.4) |
| PaO2 /供给比 |
239.0 (198.0 - -270.0) |
246.5 (213.8 - -274.0) |
188.5 (152.5 - -239.8) |
| ＜100 |
18/370 (4.9) |
5/286 (1.7) |
13/84 (15.5) |
| 100年到199年 |
77/370 (20.8) |
44/286 (15.4) |
33/84 (39.3) |
| 200年到299年 |
236/370 (63.8) |
204/286 (71.3) |
32/84 (38.1) |
| ≥300 |
39/370 (10.5) |
33/286 (11.5) |
6/84 (7.1) |
| 病毒合并感染 |
4/63 (6.3) |
3/34 (8.8) |
1/29 (3.4) |
| 细菌合并感染 |
10/109 (9.2) |
5/65 (7.7) |
5/44 (11.4) |
|
| 胸部x光特性 |
| 正常的 |
63/354 (17.8) |
56/271 (20.7) |
7/83 (8.4) |
| 兼容肺炎 |
257/354 (72.6) |
187/271 (69.0) |
70/83 (84.3) |
| 与另一种诊断相一致 |
10/354 (2.8) |
8/271 (2.9) |
2/83 (2.4) |
| 非特异性的功能 |
24/354 (6.8) |
20/271 (7.4) |
4/83 (4.8) |
|
| 胸部CT特征 |
| 与病毒性肺炎兼容 |
323/344 (93.9) |
261/274 (95.3) |
62/70 (88.6) |
| 与另一种诊断相一致 |
15/344 (4.4) |
11/274 (4.0) |
4/70 (5.7) |
| 非特异性的功能 |
6/344 (1.7) |
2/274 (0.7) |
4/70 (5.7) |
| CT肺血管造影发现肺栓塞 |
6/66 (1.6) |
6/57 (2.1) |
0/9 (0.0) |
|
|
